COMP <GO>
FUL vs TMO // DIVIDEND YIELD & FCF PAYOUT SAFETY
H. B. Fuller Company (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: FUL 3
— TMO 4
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: FUL
LAST: $49.70 (+0.02%) • MKT CAP: $2.67B
dividend-safety
1.88%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
dividend-safety
0.24%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FUL VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FUL | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.60% | 9.30% | -1.70 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.53% | 2.40% | +2.13 | FUL | /fcf-yield <GO> |
| Operating Margin | — | 17.40% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 4.40% | 15.10% | -10.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | — | 3.90% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 1.88% | 0.24% | +1.64 | FUL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.9 | 62.9 | -20.00 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.4x | 36.3x | -19.90 | FUL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.67B | $262.22B | -$259.54B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FUL REV | TMO REV | FUL GROSS % | TMO GROSS % | FUL FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.47B | $44.56B | 31.1% | — | $121.2M | $6.29B |
| FY 2024 | $3.57B | $42.88B | 29.8% | — | $163.2M | $7.27B |
| FY 2023 | $0 | $42.86B | — | — | $378.4M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FUL // BETA —
TMO // BETA 0.94